BioSpace News Archive

Business

Incyte Reports 2018 Second Quarter Financial Results and Updates on Key Clinical Programs

Total product-related revenues of $421 million in Q2 2018, representing 29 percent growth over the same period last year

July 31, 2018
·
25 min read
BioMidwest

InSitu Biologics Launches Regulation A+ Investment Opportunity for Non-Opiate Painkiller AnestaGel™

InSitu Biologics, LLC has launched a $10 million stock offering using Regulation A+.

July 31, 2018
·
2 min read
ProMIS Neurosciences Issues White Paper Entitled ‘State of the Art at AAIC 2018'

Key conference theme: targeting toxic amyloid-beta oligomers offers renewed hope for treatment of Alzheimer’s disease

July 31, 2018
·
4 min read
Drug Development

Gynecologic Oncology Publishes Results of the INNOVATE Phase 2 Pilot Study Demonstrating Combination of Tumor Treating Fields with Paclitaxel May Improve Survival of Patients with Recurrent Ovarian Cancer

Progression free survival of patients treated with Tumor Treating Fields plus weekly paclitaxel was more than double that of weekly paclitaxel-treated historical controls.

July 31, 2018
·
5 min read
Business

Q2 2018 Performance Positions Sanofi for New Growth Phase

Q2 2018 Performance Positions Sanofi for New Growth Phase

July 31, 2018
·
9 min read
Policy

Rapid Medical Receives CE Mark Approval for TIGERTRIEVER 13

The TIGERTRIEVER 13 is the smallest profile stentriever, designed to safely retrieve clots from intracranial vessels of 1mm - 2.5mm.

July 31, 2018
·
2 min read
Business

Aldeyra Therapeutics Appoints Joshua Reed as Chief Financial Officer

Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) (Aldeyra), today announced the appointment of Joshua Reed as Chief Financial Officer.

July 31, 2018
·
6 min read
Policy

Eiger BioPharmaceuticals Announces Notice of Allowance for U.S. Patent Covering a Broad Range of Ritonavir-Boosted Lonafarnib Dosing Regimens for Treatment of Hepatitis Delta Virus Infection

Eiger BioPharmaceuticals, Inc. announced that it has received the Notice of Allowance from the United States Patent and Trademark Office (USPTO) for U.S. patent application number 15/335,327, entitled “Treatment of Hepatitis Delta Virus Infection.”

July 31, 2018
·
5 min read
Business

Sensus Healthcare CEO Receives “Innovator of the Year” Award at The Aesthetic Show 2018

Sensus Also Named Runner-Up “Company Innovator of the Year”

July 31, 2018
·
6 min read
Drug Development

Audentes to Release Second Quarter 2018 Financial Results and Provide Update on ASPIRO, the Phase 1/2 study of AT132 in Patients with X-Linked Myotubular Myopathy

ASPIRO update to include 24-week clinical data and muscle biopsy results from the first three treated patients

July 31, 2018
·
2 min read